Study shows monoclonal antibody can lower common lung infection risk
New Delhi, June 5 (IANS) A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections in infants can halve hospitalisations for bronchiolitis, according to a… Continue reading Study shows monoclonal antibody can lower common lung infection risk











